Blood test plus ultrasound boosts liver cancer detection by 40 percent

February 9, 2018 by Cathy Frisinger, UT Southwestern Medical Center

Combining ultrasound imaging with a blood test for high alpha fetoprotein (AFP) levels improves detection of early-stage liver cancer by as much as 40 percent, researchers at UT Southwestern's Simmons Cancer Center found.

Earlier detection is important to improving survival of patients with , a disease that is on the rise and the fastest increasing solid-tumor in the U.S., according to the National Cancer Institute (NCI).

"If the cancer is found early, then we can perform curative therapies, allowing patients to live many years," said hepatologist Dr. G. Amit Singal, Associate Professor of Internal Medicine and Clinical Sciences with UT Southwestern Harold C. Simmons Comprehensive Cancer Center. "Unfortunately, most liver cancer in the United States is discovered at later stages, when curative treatment is not possible and survival is much worse."

While the incidence of most cancers is decreasing in the U.S., the incidence of liver cancer has increased by 2.7 percent a year over the last 10 years, according to the NCI, which estimated about 40,700 new cases of liver cancer will be diagnosed in the U.S. in 2018. Risk factors for liver cancer, also known as hepatocellular carcinoma or HCC, include hepatitis C infection, chronic heavy alcohol consumption, and nonalcoholic fatty related to diabetes and obesity. Symptoms can include upper abdominal pain or swelling, loss of weight or appetite, white chalky stools, and general fatigue.

Liver cancer screening guidelines for patients with cirrhosis vary, with some guidelines calling for just imaging and other guidelines calling for both imaging and AFP measurement.

"Liver cancer screening in patients with has traditionally been performed using an abdominal ultrasound. While ultrasound is readily available and noninvasive, it misses many cancers when they are small," said Dr. Amit Singal, who holds the David Bruton, Jr. Professorship in Clinical Cancer Research. "Our study found that adding the blood biomarker alpha fetoprotein increased detection of early-stage hepatocellular carcinoma from 45 percent with ultrasound alone to 63 percent using the two tests in combination.

AFP is a plasma protein that is produced in abundance by the liver cells in the fetus. In adults, AFP levels are normally low, but liver cancer can cause AFP levels to rise.

The research, a meta-analysis of 32 previous studies, appears in the journal Gastroenterology.

Collaborators on the study included Dr. Jorge Marrero, Professor of Internal Medicine, and Dr. Adam Yopp, Associate Professor of Surgery, also members of the Simmons Cancer Center, one of just 49 NCI-designated Comprehensive Cancer Centers in the nation and the only NCI-designated Comprehensive Cancer Center in North Texas.

Simmons Cancer Center is among just 30 U.S. cancer research centers to be designated by the NCI as a National Clinical Trials Network Lead Academic Participating Site.

"Our results highlight the importance of continued development and validation of blood-based biomarkers for liver cancer early detection. Most important, our results support a change in clinical practice and the routine use of ultrasound and biomarkers together for cancer screening," said Dr. Singal, Dedman Family Scholar in Clinical Care at UT Southwestern, which is recognizing its 75th anniversary this year.

Explore further: Liver cancer screening highly beneficial for people with cirrhosis

Related Stories

Liver cancer screening highly beneficial for people with cirrhosis

May 5, 2014
Liver cancer survival rates could be improved if more people with cirrhosis are screened for tumors using inexpensive ultrasound scans and blood tests, according to a review by doctors at UT Southwestern Medical Center.

Outreach to cirrhosis patients doubles early screening rates for deadly liver cancer

November 18, 2016
Proactive outreach to cirrhosis patients in a safety net health system successfully doubled their screening rates for liver cancer, UT Southwestern Medical Center researchers found.

Screening for liver cancer in patients with cirrhosis

April 1, 2014
In a systematic review and meta-analysis of 47 studies with 15,158 patients, Amit Singal (University of Texas Southwestern Medical Center) and colleagues found that patients with cirrhosis who underwent surveillance (via ...

Contrast-enhanced ultrasound no aid for metastasis detection

December 15, 2017
(HealthDay)—Contrast-enhanced laparoscopic ultrasonography (CE-LUS) does not appear to increase the detection rate of liver metastasis during robotic-assisted surgery for primary colorectal cancer (CRC), according to a ...

Can aspirin stop liver cancer in hepatitis B patients?

October 20, 2017
(HealthDay)—Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests.

Hepatitis B viral load, surface antigen may ID liver cancer risk

November 1, 2017
(HealthDay)—Elevated levels of hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) are associated with increased risks of liver cancer, according to a study published online Oct. 24 in the Journal of Gastroenterology ...

Recommended for you

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Study finds gut microbiome can control antitumor immune function in liver

May 24, 2018
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published May 25 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.